Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Consumables, Instruments, Biopsy Instruments), By Technology (IVD Testing, Imaging, Biopsy Technique), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Others), By End-User (Hospitals, Diagnostic Laboratories), by Country, Segment, and Companies, 2024-2032
The global Cancer Diagnostics market size is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Diagnostics market across By Product (Consumables, Instruments, Biopsy Instruments), By Technology (IVD Testing, Imaging, Biopsy Technique), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Others), By End-User (Hospitals, Diagnostic Laboratories)
The cancer diagnostics market is driven by the increasing incidence of cancer, advancements in diagnostic imaging and laboratory testing, and the emphasis on early detection and prevention. By 2030, the market is poised to witness steady growth, fueled by innovations in imaging modalities, molecular diagnostics, and liquid biopsy technologies. Further, expanding applications in cancer screening programs, companion diagnostics, and point-of-care testing are expected to drive market expansion, enabling healthcare providers to detect cancer at earlier stages, guide treatment decisions, and improve patient survival rates through timely and accurate diagnosis.
Cancer Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cancer Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cancer Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cancer Diagnostics industry.
Key market trends defining the global Cancer Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cancer Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Cancer Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cancer Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cancer Diagnostics industry
Leading Cancer Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cancer Diagnostics companies.
Cancer Diagnostics Market Study- Strategic Analysis Review
The Cancer Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Cancer Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Cancer Diagnostics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Cancer Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Cancer Diagnostics market segments. Similarly, Strong market demand is encouraging Canadian Cancer Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Cancer Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cancer Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cancer Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Cancer Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cancer Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cancer Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Cancer Diagnostics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Cancer Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cancer Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cancer Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cancer Diagnostics.
Cancer Diagnostics Market Company Profiles
The global Cancer Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, F. Hoffmann-La Roche Ltd, GE Healthcare, QIAGEN N.V., Becton, Dickinson and Company, Koninklijke Philips N.V. , Siemens Healthcare GmbH, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc.
Recent Cancer Diagnostics Market Developments
The global Cancer Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cancer Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Consumables
Instruments
Biopsy Instruments
By Technology
IVD Testing
-Polymerase Chain Reaction (PCR)
-In Situ Hybridization (ISH)
-Immunohistochemistry (IHC)
-Next-generation Sequencing (NGS)
-Microarrays
-Flow Cytometry
-Immunoassays
-Others
Imaging
-Magnetic Resonance Imaging (MRI)
-Computed Tomography (CT)
- Positron Emission Tomography (PET)
-Mammography
-Ultrasound
Biopsy Technique
By Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others
By End-User
Hospitals
Diagnostic Laboratories
Geographical Segmentation:
Abbott Laboratories
F. Hoffmann-La Roche Ltd
GE Healthcare
QIAGEN N.V.
Becton, Dickinson and Company
Koninklijke Philips N.V.
Siemens Healthcare GmbH
Hologic Inc
Thermo Fisher Scientific Inc
Illumina Inc
Formats Available: Excel, PDF, and PPT
The cancer diagnostics market is driven by the increasing incidence of cancer, advancements in diagnostic imaging and laboratory testing, and the emphasis on early detection and prevention. By 2030, the market is poised to witness steady growth, fueled by innovations in imaging modalities, molecular diagnostics, and liquid biopsy technologies. Further, expanding applications in cancer screening programs, companion diagnostics, and point-of-care testing are expected to drive market expansion, enabling healthcare providers to detect cancer at earlier stages, guide treatment decisions, and improve patient survival rates through timely and accurate diagnosis.
Cancer Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cancer Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cancer Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cancer Diagnostics industry.
Key market trends defining the global Cancer Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cancer Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Cancer Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cancer Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cancer Diagnostics industry
Leading Cancer Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cancer Diagnostics companies.
Cancer Diagnostics Market Study- Strategic Analysis Review
The Cancer Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Cancer Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Cancer Diagnostics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Cancer Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Cancer Diagnostics market segments. Similarly, Strong market demand is encouraging Canadian Cancer Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Cancer Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cancer Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cancer Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Cancer Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cancer Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cancer Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Cancer Diagnostics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Cancer Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cancer Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cancer Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cancer Diagnostics.
Cancer Diagnostics Market Company Profiles
The global Cancer Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, F. Hoffmann-La Roche Ltd, GE Healthcare, QIAGEN N.V., Becton, Dickinson and Company, Koninklijke Philips N.V. , Siemens Healthcare GmbH, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc.
Recent Cancer Diagnostics Market Developments
The global Cancer Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cancer Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Consumables
Instruments
Biopsy Instruments
By Technology
IVD Testing
-Polymerase Chain Reaction (PCR)
-In Situ Hybridization (ISH)
-Immunohistochemistry (IHC)
-Next-generation Sequencing (NGS)
-Microarrays
-Flow Cytometry
-Immunoassays
-Others
Imaging
-Magnetic Resonance Imaging (MRI)
-Computed Tomography (CT)
- Positron Emission Tomography (PET)
-Mammography
-Ultrasound
Biopsy Technique
By Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others
By End-User
Hospitals
Diagnostic Laboratories
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
F. Hoffmann-La Roche Ltd
GE Healthcare
QIAGEN N.V.
Becton, Dickinson and Company
Koninklijke Philips N.V.
Siemens Healthcare GmbH
Hologic Inc
Thermo Fisher Scientific Inc
Illumina Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Cancer Diagnostics Market Overview and Key Findings, 2024
1.2 Cancer Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Cancer Diagnostics Market Growth Opportunities to 2030
1.4 Key Cancer Diagnostics Market Trends and Challenges
1.4.1 Cancer Diagnostics Market Drivers and Trends
1.4.2 Cancer Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cancer Diagnostics Companies
2. CANCER DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Cancer Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Cancer Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CANCER DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CANCER DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Consumables
Instruments
Biopsy Instruments
By Technology
IVD Testing
-Polymerase Chain Reaction (PCR)
-In Situ Hybridization (ISH)
-Immunohistochemistry (IHC)
-Next-generation Sequencing (NGS)
-Microarrays
-Flow Cytometry
-Immunoassays
-Others
Imaging
-Magnetic Resonance Imaging (MRI)
-Computed Tomography (CT)
- Positron Emission Tomography (PET)
-Mammography
-Ultrasound
Biopsy Technique
By Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others
By End-User
Hospitals
Diagnostic Laboratories
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cancer Diagnostics Market, 2025
5.2 Asia Pacific Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cancer Diagnostics Market, 2025
5.5 Europe Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cancer Diagnostics Market, 2025
5.8 North America Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cancer Diagnostics Market, 2025
5.11 South America Pacific Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cancer Diagnostics Market, 2025
5.14 Middle East Africa Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cancer Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Cancer Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cancer Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cancer Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cancer Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cancer Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cancer Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cancer Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cancer Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cancer Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cancer Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cancer Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cancer Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cancer Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cancer Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cancer Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cancer Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cancer Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cancer Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cancer Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cancer Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cancer Diagnostics Industry Drivers and Opportunities
7. CANCER DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CANCER DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Cancer Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
F. Hoffmann-La Roche Ltd
GE Healthcare
QIAGEN N.V.
Becton, Dickinson and Company
Koninklijke Philips N.V.
Siemens Healthcare GmbH
Hologic Inc
Thermo Fisher Scientific Inc
Illumina Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Cancer Diagnostics Market Overview and Key Findings, 2024
1.2 Cancer Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Cancer Diagnostics Market Growth Opportunities to 2030
1.4 Key Cancer Diagnostics Market Trends and Challenges
1.4.1 Cancer Diagnostics Market Drivers and Trends
1.4.2 Cancer Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cancer Diagnostics Companies
2. CANCER DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Cancer Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Cancer Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CANCER DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CANCER DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Consumables
Instruments
Biopsy Instruments
By Technology
IVD Testing
-Polymerase Chain Reaction (PCR)
-In Situ Hybridization (ISH)
-Immunohistochemistry (IHC)
-Next-generation Sequencing (NGS)
-Microarrays
-Flow Cytometry
-Immunoassays
-Others
Imaging
-Magnetic Resonance Imaging (MRI)
-Computed Tomography (CT)
- Positron Emission Tomography (PET)
-Mammography
-Ultrasound
Biopsy Technique
By Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others
By End-User
Hospitals
Diagnostic Laboratories
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cancer Diagnostics Market, 2025
5.2 Asia Pacific Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cancer Diagnostics Market, 2025
5.5 Europe Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cancer Diagnostics Market, 2025
5.8 North America Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cancer Diagnostics Market, 2025
5.11 South America Pacific Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cancer Diagnostics Market, 2025
5.14 Middle East Africa Cancer Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cancer Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cancer Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Cancer Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cancer Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cancer Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cancer Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cancer Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cancer Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cancer Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cancer Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cancer Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cancer Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cancer Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cancer Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cancer Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cancer Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cancer Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cancer Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cancer Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cancer Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cancer Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cancer Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cancer Diagnostics Industry Drivers and Opportunities
7. CANCER DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CANCER DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Cancer Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
F. Hoffmann-La Roche Ltd
GE Healthcare
QIAGEN N.V.
Becton, Dickinson and Company
Koninklijke Philips N.V.
Siemens Healthcare GmbH
Hologic Inc
Thermo Fisher Scientific Inc
Illumina Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
